GAIN THERAPEUTICS, INC Other Receivables, Net, Current
GAIN THERAPEUTICS, INC (GANX) had Other Receivables, Net, Current of $33.26 thousand as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Notes
us-gaap:OtherReceivablesNetCurrent · last filed 2024-03-26
- 2023-03-31: Other Receivables, Net, Current $33.26K.
- 2022-12-31: Other Receivables, Net, Current $87.43K.
- 2022-09-30: Other Receivables, Net, Current $101.92K.
- 2022-06-30: Other Receivables, Net, Current $95.99K.
| Period end | Other Receivables, Net, Current |
|---|---|
| 2023-03-31 | $33.26K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $87.43K 10-K · filed 2024-03-26 |
| 2022-09-30 | $101.92K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $95.99K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $94.86K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $81.86K 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |